Patents by Inventor John Prescott

John Prescott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Toxins in type A
    Patent number: 9505810
    Abstract: The present disclosure relates to novel pore-forming toxins of Type A C. perfringens and immunogenic compositions and vaccines thereof. The present disclosure further relates to methods and uses of treating or preventing enteric disease and assays for diagnosing enteric disease.
    Type: Grant
    Filed: August 21, 2015
    Date of Patent: November 29, 2016
    Assignee: University of Guelph
    Inventors: John Prescott, Iman Mehdizadeh Gohari, Valeria Parreira Pinto
  • Toxin in type A
    Patent number: 9493519
    Abstract: The present disclosure relates to a novel toxin of Type A C. perfringens and immunogenic compositions and vaccines thereof. The present disclosure further relates to methods and uses of treating or preventing enteric disease and assays for diagnosing enteric disease in mammals.
    Type: Grant
    Filed: May 23, 2013
    Date of Patent: November 15, 2016
    Assignee: University of Guelph
    Inventors: John Prescott, Iman Mehdizadeh Gohari, Valeria Parreira Pinto
  • Vaccine against
    Patent number: 9399058
    Abstract: There is provided a vaccine for controlling Clostridium perfringens in animals, and particularly necrotic enteritis in poultry. The vaccine may comprise a C. perfringens antigenic polypeptide or variant thereof, a nucleic acid encoding the C. perfringens antigenic polypeptide or variant thereof, or a recombinant cell producing the C. perfringens antigenic polypeptide or variant thereof.
    Type: Grant
    Filed: July 22, 2013
    Date of Patent: July 26, 2016
    Assignee: University of Guelph
    Inventors: John Prescott, Raveendra Kulkarni, Valeria Parreira, Shayan Sharif
  • NOVEL TOXINS IN TYPE A CLOSTRIDIUM PERFRINGENS
    Publication number: 20160052977
    Abstract: The present disclosure relates to novel pore-forming toxins of Type A C. perfringens and immunogenic compositions and vaccines thereof. The present disclosure further relates to methods and uses of treating or preventing enteric disease and assays for diagnosing enteric disease.
    Type: Application
    Filed: August 21, 2015
    Publication date: February 25, 2016
    Inventors: John Prescott, Iman Mehdizadeh Gohari, Valeria Parreira Pinto
  • NOVEL TOXIN IN TYPE A CLOSTRIDIUM PERFRINGENS
    Publication number: 20150158917
    Abstract: The present disclosure relates to a novel toxin of Type A C. perfringens and immunogenic compositions and vaccines thereof. The present disclosure further relates to methods and uses of treating or preventing enteric disease and assays for diagnosing enteric disease in mammals.
    Type: Application
    Filed: May 23, 2013
    Publication date: June 11, 2015
    Inventors: John Prescott, Iman Mehdizadeh Gohari, Valeria Parreira Pinto
  • Automated corrective and predictive maintenance system
    Patent number: 8660875
    Abstract: A method and system for automated corrective and predictive maintenance is described herein. In one embodiment, a failure notification associated with a tool is received, wherein the failure notification indicates one or more failure events for the tool. Maintenance data associated with the tool is obtained, wherein the maintenance data includes one or more maintenance events for the tool. An optimal schedule is created for the tool by merging the failure notification and the maintenance data.
    Type: Grant
    Filed: November 1, 2010
    Date of Patent: February 25, 2014
    Assignee: Applied Materials, Inc.
    Inventors: Manjunath Yedatore, Deepak Bhatia, John Prescott
  • VACCINE AGAINST CLOSTRIDIUM PERFRINGENS
    Publication number: 20130295127
    Abstract: There is provided a vaccine for controlling Clostridium perfringens in animals, and particularly necrotic enteritis in poultry. The vaccine may comprise a C. perfringens antigenic polypeptide or variant thereof, a nucleic acid encoding the C. perfringens antigenic polypeptide or variant thereof, or a recombinant cell producing the C. perfringens antigenic polypeptide or variant thereof.
    Type: Application
    Filed: July 22, 2013
    Publication date: November 7, 2013
    Inventors: John Prescott, Raveendra Kulkarni, Valeria Parreira, Shayan Sharif
  • Vaccine against
    Patent number: 8501190
    Abstract: There is provided a vaccine for controlling Clostridium perfringens in animals, and particularly necrotic enteritis in poultry. The vaccine may comprise a C. perfringens antigenic polypeptide or variant thereof, a nucleic acid encoding the C. perfringens antigenic polypeptide or variant thereof, or a recombinant cell producing the C. perfringens antigenic polypeptide or variant thereof.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: August 6, 2013
    Assignee: The University of Guelph
    Inventors: John Prescott, Raveendra Kulkarni, Valeria Parreira, Shayan Sharif
  • AUTOMATED CORRECTIVE AND PREDICTIVE MAINTENANCE SYSTEM
    Publication number: 20110137697
    Abstract: A method and system for automated corrective and predictive maintenance is described herein. In one embodiment, a failure notification associated with a tool is received, wherein the failure notification indicates one or more failure events for the tool. Maintenance data associated with the tool is obtained, wherein the maintenance data includes one or more maintenance events for the tool. An optimal schedule is created for the tool by merging the failure notification and the maintenance data.
    Type: Application
    Filed: November 1, 2010
    Publication date: June 9, 2011
    Inventors: MANJUNATH YEDATORE, Deepak Bhatia, John Prescott
  • COMBINATIONS OF A PI3K INHIBITOR AND A MEK INHIBITOR
    Publication number: 20110086837
    Abstract: The invention relates methods of treating a patient with locally advanced or metastatic solid tumors with a combination of an inhibitor of phosphatidylinositol 3-kinase (PI 3-kinase or PI3K) and an inhibitor of mitogen activated protein kinase (MEK) described herein.
    Type: Application
    Filed: October 11, 2010
    Publication date: April 14, 2011
    Applicant: Genentech, Inc.
    Inventors: Marcia Belvin, Iris T. Chan, Lori Friedman, Klaus P. Hoeflich, John Prescott, Jeffrey Wallin
  • VACCINE AGAINST CLOSTRIDIUM PERFRINGENS
    Publication number: 20100255022
    Abstract: There is provided a vaccine for controlling Clostridium perfringens in animals, and particularly necrotic enteritis in poultry. The vaccine may comprise a C. perfringens antigenic polypeptide or variant thereof, a nucleic acid encoding the C. perfringens antigenic polypeptide or variant thereof, or a recombinant cell producing the C. perfringens antigenic polypeptide or variant thereof.
    Type: Application
    Filed: May 30, 2008
    Publication date: October 7, 2010
    Applicant: UNIVERSITY OF GUELPH
    Inventors: John Prescott, Raveendra Kulkarni, Valeria Parreira, Shayan Sharif
  • Extended tethering approach for rapid identification of ligands
    Publication number: 20050186630
    Abstract: The invention concerns a method for rapid identification and characterization of binding partners for a target molecule, and for providing binding partners with improved binding affinity. More specifically, the invention concerns an improved tethering method for the rapid identification of at least two binding partners that bind near one another to a target molecule.
    Type: Application
    Filed: April 15, 2005
    Publication date: August 25, 2005
    Inventors: Daniel Erlanson, Andrew Braisted, Robert McDowell, John Prescott
  • Extended tethering approach for rapid identification of ligands
    Patent number: 6919178
    Abstract: The invention concerns a method for rapid identification and characterization of binding partners for a target molecule, and for providing binding partners with improved binding affinity. More specifically, the invention concerns an improved tethering method for the rapid identification of at least two binding partners that bind near one another to a target molecule.
    Type: Grant
    Filed: November 21, 2001
    Date of Patent: July 19, 2005
    Assignee: Sunesis Pharmaceuticals, Inc.
    Inventors: Daniel A. Erlanson, Andrew C. Braisted, Robert McDowell, John Prescott
  • Identification of kinase inhibitors
    Publication number: 20050084905
    Abstract: The invention concerns the identification of protein kinase inhibitors that preferentially bind to the inactive conformation of a target protein kinase. The inhibitors are identified by locking the target protein kinase in an inactive conformation, and using Tethering to identify inhibitors preferentially targeting the inactive conformation.
    Type: Application
    Filed: September 17, 2003
    Publication date: April 21, 2005
    Inventors: John Prescott, Andrew Braisted, Joelle Morrow
  • Extended tethering approach for rapid identification of ligands
    Publication number: 20020150947
    Abstract: The invention concerns a method for rapid identification and characterization of binding partners for a target molecule, and for providing binding partners with improved binding affinity. More specifically, the invention concerns an improved tethering method for the rapid identification of at least two binding partners that bind near one another to a target molecule.
    Type: Application
    Filed: November 21, 2001
    Publication date: October 17, 2002
    Inventors: Daniel A. Erlanson, Andrew C. Braisted, Robert McDowell, John Prescott